JACOBS LEVY EQUITY MANAGEMENT, INC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 168 filers reported holding NEKTAR THERAPEUTICS in Q3 2015. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2023$2,921,266
+4.3%
4,904,745
+0.7%
0.02%
+6.2%
Q2 2023$2,801,499
+52.2%
4,870,478
+86.0%
0.02%
+45.5%
Q1 2023$1,840,253
-68.3%
2,618,087
+1.8%
0.01%
-71.8%
Q4 2022$5,810,119
+75.0%
2,570,849
+147.7%
0.04%
+50.0%
Q3 2022$3,321,000
+283.5%
1,037,929
+355.3%
0.03%
+271.4%
Q2 2022$866,000
-31.0%
227,963
+145.3%
0.01%
-12.5%
Q4 2021$1,255,000
-19.8%
92,917
+6.7%
0.01%
-27.3%
Q3 2021$1,564,000
+257.9%
87,082
+241.8%
0.01%
+266.7%
Q2 2021$437,000
+11.5%
25,481
+30.0%
0.00%0.0%
Q1 2021$392,000
-69.4%
19,607
-74.0%
0.00%
-72.7%
Q4 2020$1,283,000
+0.7%
75,476
-1.7%
0.01%
-15.4%
Q3 2020$1,274,000
-6.0%
76,781
+31.2%
0.01%
-13.3%
Q2 2020$1,355,000
+731.3%
58,525
+392.6%
0.02%
+400.0%
Q1 2016$163,000
-95.3%
11,880
-95.7%
0.00%
-95.5%
Q2 2015$3,487,000
+197.0%
278,740
+161.1%
0.07%
+230.0%
Q1 2015$1,174,000
-84.5%
106,750
-78.2%
0.02%
-84.6%
Q4 2014$7,585,000
+73.7%
489,386
+35.3%
0.13%
+78.1%
Q3 2014$4,367,000
+16.1%
361,786
+23.3%
0.07%
+17.7%
Q2 2014$3,761,000
+293.4%
293,386
+248.4%
0.06%
+342.9%
Q4 2013$956,000
-11.5%
84,210
-18.5%
0.01%
-22.2%
Q3 2013$1,080,000103,3800.02%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2015
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 598,400$10,083,0003.98%
Opus Point Partners Management, LLC 348,583$5,874,0003.88%
Camber Capital Management LP 3,500,000$58,975,0003.81%
1492 Capital Management LLC 180,601$3,043,0002.21%
Virtus ETF Advisers LLC 38,260$645,0001.77%
Cormorant Asset Management, LP 765,156$12,893,0001.54%
Rhenman & Partners Asset Management AB 581,000$9,790,0001.48%
Granahan Investment Management 2,082,155$35,084,0001.21%
BRIDGER MANAGEMENT, LLC 1,563,862$26,351,0000.87%
RICE HALL JAMES & ASSOCIATES, LLC 899,531$15,157,0000.87%
View complete list of NEKTAR THERAPEUTICS shareholders